Surgery for spinal metastases remains the mainstay treatment for pain, instability, and neurological deterioration due to tumor infiltration of the spine. However, several new therapies are emerging which may improve outcomes further, and in some cases even replace the need for surgery. We now have a better understanding of which factors influence survival and quality of life after surgery, and this underpins the development and application of new treatments, and assessment of outcome. Depending on genetic subtyping of tumors, novel immunotherapies and chemotherapies may be very effective in prolonging quality of life. New surgical techniques allow smaller, quicker, and safer operations with less blood loss, pain, and quicker recovery after surgery. Radiation treatments have also leapt forward with the greater accuracy and higher doses possible from intensity-modulated photon radiation, stereotactic body radiation treatment, proton beam therapy, or carbon ion treatment. Combined with more advanced materials for vertebral body stabilization, computer navigation systems, and robotics, more can be done at earlier or later stages of the spinal disease than was previously possible, resulting in more options and improved outcomes for patients.
S
urgery for symptomatic spinal metastases can improve pain, neurological function, and quality of life. [1] [2] [3] In recent years, there have been several advances that contribute to better outcomes for this common disease. Understanding the factors that influence duration of survival and quality of life can help doctors and patients to make appropriate treatment decisions, 2, [4] [5] [6] and genetic subtyping, novel immunotherapies, and advances in radiation techniques have allowed personalized treatment for patient benefit. Advances in surgical techniques permit minimally invasive augmentation of vertebral body integrity without resorting to larger open surgeries, and thereby decrease pain and allow rapid recovery from surgery. Percutaneous cement augmentation, vertebral body stenting or support, and percutaneous instrumentation have increased the acces-ABBREVIATIONS: SBRT, stereotactic body radiotherapy; PMMA, Polymethylmethacrylate; PEEK, poly-ether-ether-ketone; SINS, Spinal Instability Neoplastic Score sibility of surgical treatments to patients with poorer prognosis. New materials and devices for spine reconstruction can make surgery easier, and radiolucent materials permit more effective radiation treatments and radiological surveillance after surgery. Three-dimensional printing allows bespoke manufacture of components to reconstruct the spine, or produce patientspecific models of the spine to allow the surgeon to plan tumor resection and reconstruction more effectively. The availability of computer navigation systems and robotic guidance allows accurate resection, implant placement, and better appreciation of abnormal or complex anatomy.
PERSONALIZED TREATMENT Genetic Subtype Analysis
Genetic analysis of tumors has revolutionized medical management of metastatic tumors, particularly breast carcinoma, melanoma, and certain lung carcinomas. 7, 8 For nonsmall cell lung cancer, if genetic analysis is positive for epidermal growth factor NEUROSURGERY VOLUME 80 | NUMBER 3 | MARCH 2017 Supplement | S131 receptor mutation, then patients may respond well to immunotherapy (erlotinib 9 ) and chemotherapy (pemetrexedcisplatin 10 ) with a favorable median survival of greater than 2 years. If genetic analysis is positive for anaplastic lymphoma kinase-echinoderm microtubule-associated protein-like 4 fusion, then immunotherapy with crizotinib may be used.
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Renal cell carcinoma can be resistant to radiotherapy and traditional chemotherapy, but may respond well to new immunotherapies (sunitinib and pazopanib) with more than 50% disease control rate. 12 Melanoma with positive BRAF mutation may also respond well to immunotherapies with improved survival even in advanced metastatic disease.
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Prognostication and Risk Assessment
Prognostic scores allow an estimation of survival and quality of life which may guide treatment decisions. It is important to tailor the most appropriate operation for an individual patient; too much surgery, or performing surgery too late, may not benefit a patient, and conversely, too conservative an approach may deny a patient the chance to walk or have improved quality of life. Prognostic scoring systems allow a better understanding of the risk of the spine tumor to the patient, estimating survival and quality of life. In general, larger operations may potentially improve longterm outcomes, but are perhaps more likely to be associated with surgical complications that could negate the benefits of surgery. To select appropriate operations, it is useful (although not always easy) to estimate whether a patient may not tolerate surgery or live long enough to appreciate the effects of surgery.
The most cited scoring systems for metastatic spine tumors are the Tomita score 4 and the Tokuhashi score, 5 which comprise the primary tumor type, presence of visceral metastases, number of spinal metastases, and in addition the Tokuhashi score incorporates the neurological function and Karnofsky functional status into the score. These systems have been previously validated, 2, 14, 15 and although there are limitations to their application, they remain useful tools to aid surgical decision-making. Other prognostic scoring systems follow similar methodologies, but place emphasis and weighting on different variables. 16 However, in this present decade, genetic subtype analysis has allowed the prognosis of certain tumor types to be estimated more specifically for an individual. Prognosis of some tumors is defined more by their genetic subtype analysis rather than other factors at presentation. Although generalized prognostic scoring systems still have their uses, their wider acceptance and adoption into clinical practice has been limited and some surgeons have questioned their validity, 17 particularly since prognosis is perhaps more influenced now by genetic subtyping. For example, if a melanoma metastasis has a BRAF mutation in the genetic phenotype of the primary tumor, then survival is influenced by the response to immunotherapy rather than by the number of spinal and visceral metastases at presentation. The same can be said for epidermal growth factor receptor status in nonsmall cell lung carcinoma, and estrogen, progesterone, or HER2 receptor status in breast carcinoma. Therefore, rather than relying on prognostic scoring systems, the more "modern" approach would be to create a risk stratification model including the genetic subtype of the metastasis, as well as the Tomita 4 or Tokuhashi 5 elements, to determine a median survival for an individual patient at the time that they present to the surgeon. It is important for the modern spine surgeon to understand primary tumor biology and how this impacts on prognosis and consequently the choice of surgery.
ADVANCES IN RADIATION AND HEAVY PARTICLE THERAPIES
Traditionally, surgical management would precede adjunctive radiation treatments. However, with the advent of modern radiotherapy, including intensity-modulated radiotherapy, stereotactic radiosurgery and stereotactic body radiotherapy (SBRT), and heavy particle therapies, the landscape has shifted. If there is no imminent instability or symptomatic spinal cord compression, these techniques may be used before or instead of surgery. Surgery, rather than aiming to completely excise a tumor, may now be performed with the objective of "separation surgery" to create sufficient space around crucial structures such as the spinal cord to allow dose escalation of radiotherapy techniques while limiting collateral damage to the spinal cord. Early evidence demonstrates that separation surgery is effective in local disease control, although there is little data to determine the degree of separation which is required to permit adequate radiotherapy dose escalation and good outcomes. 18 Radiation treatments have seen a revolution in the past decade, with the introduction of SBRT 19, 20 and heavy particle therapy such as proton beam or carbon ion treatments. Tumors which were previously resistant to conventional radiotherapy are now sensitive to higher dose conformal therapies. Whereas there is little published evidence for the efficacy of heavy particle treatment for spinal metastases, the principal benefits would be similar to SBRT, with higher delivered dosage and less collateral damage. SBRT has been used for primary treatment, postoperative treatment, and for salvage reirradiation. A treatment dose of stereotactic radiotherapy can be given to early metastases to minimize progression to spinal cord compression or mechanical instability, particularly for radioresistant tumors such as renal cell carcinoma, sarcoma, and melanomas. If there is significant instability or spinal cord compression, primary surgical management is preferable to SBRT, although SBRT may be used as a postoperative adjunct after minimal access surgery. 19 In addition to local disease control, SBRT may also have a significant role in palliative treatment of patients with end-stage disease, resulting in pain control in 80% to 85% of patients. 21 However, one must bear in mind that focused high-dose radiation therapies such as SBRT can be associated with delayed vertebral fracture in 11% to 39% of patients and therefore strategies to anticipate and mitigate this risk, including prophylactic vertebroplasty, should be considered.
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ADVANCES IN SURGICAL TECHNIQUE
Several new techniques have been developed over the past decade to make surgery for spinal metastases safer and more acceptable to patients by decreasing postoperative pain and length of hospital stay. Minimal access techniques are a useful addition to the range of techniques that a spine tumor surgeon should be familiar with. However, "one size does not fit all" and the choice of technique will depend on surgeon-related factors such as technical ability and familiarity with newer techniques, and patient-related factors including the indication for surgery (pain control, stability, decompression, or separation surgery) and the patient's prognosis. Preoperative MRI and CT imaging of the spine are essential to appreciate the anatomic goals of surgery and the potential limitations of certain approaches. Minimal access techniques in general are associated with a learning curve and require additional training, due to the relatively narrow working channels or approaches, longer working distances, and challenges posed by excessive bleeding or CSF leakage.
Percutaneous Vertebral Body Augmentation
Less invasive techniques potentially allow quicker recovery, lower complication rates, and increased versatility for treating palliative patients who have a poorer prognosis. The introduction of percutaneous cement techniques for osteoporotic vertebral body compression fractures has been successfully applied to pathological fractures due to spinal metastases. Vertebroplasty involves the injection of viscous Polymethylmethacrylate (PMMA) bone cement in Situ to provide structural integrity within the weakened vertebral body. 23, 24 Xie et al 23 reported decreased pain visual analog score from around 8.4 to 3.4 after vertebroplasty in 47 patients with spinal metastases. Kyphoplasty, by temporarily inflating a balloon within the affected vertebral body, creates a cavity which can be filled with bone cement at lower injection pressure than vertebroplasty, and may also permit reduction of a wedge fracture. 25 Alternative techniques to improve pathological wedging include mechanical elevation of the end plate using an expandable jack 26 or using a titanium mesh vertebral body stent that expands over an inflatable balloon. 27 Previously, radiotherapy was the treatment of choice for patients with poor prognosis or who were unable to tolerate surgery. However, the increased availability of percutaneous vertebral body augmentation has expanded the range of indications for surgical intervention to include palliative control of pain and instability in the absence of significant cord compression. These techniques minimize the collateral damage, which can occur with radiation treatments, and may provide the rapid benefits of surgery with minimal complications. Vertebroplasty can also be used in conjunction with percutaneous or open pedicle screw insertion and may minimize the number of levels requiring fixation.
Use of the procedure, however, may be limited by areas of cortical lysis in the posterior wall of the vertebral body, leakage of cement, and potential damage to spinal cord or nerve roots. Contraindications include the presence of infection, coagulation disorders, or excessive collapse (loss of greater than two-thirds vertebral body height).
Percutaneous Radiofrequency Ablation
With the development of percutaneous access to the vertebral body for cement augmentation, other techniques have been developed to ablate tumor in an attempt to improve spinal pain and possibly decrease the risk of cord compression. Since the electrode insertion technique is similar to percutaneous cement augmentation, radiofrequency ablation can be performed at the same time as percutaneous cement augmentation, or as an independent procedure to destroy tumor tissue within the vertebral body. 28, 29 Long-term outcomes are unclear, but this technology may be a useful addition to the minimally invasive methods available for palliative treatment.
Indications for radiofrequency ablation include unresectable osteolytic metastases, patients who are unfit for surgery, poor prognosis, or when conventional options of radiotherapy or chemotherapy are unlikely to be effective. Contraindications include implanted electronic devices such as pacemakers. The procedure should be used with care if the tumor is within 1 cm of the spinal cord, and extradural temperature monitoring and saline irrigation should be used to minimize thermal transmission.
Minimal Access Retractor Systems
Anterior approaches to the vertebral body in the thoracolumbar spine are facilitated by minimal access retractor systems, which allow smaller skin incisions and direct approaches to the surgical target. Corpectomy and stabilization with an expandable vertebral body replacement prosthesis is now possible with minimal tissue damage, allowing rapid patient mobilization and discharge from hospital, without the morbidity of major thoracotomy or anterolateral abdominal approaches. Transferring open surgical skills to using minimal access retractors is relatively straightforward and intuitive, unlike the steeper learning curve of endoscopic surgical techniques. 30 Although there is limited evidence of efficacy of minimal access techniques, and most published series are uncontrolled and report small numbers of patients, the general consensus is that these approaches decrease bleeding and pain compared to traditional open approaches, as discussed in 2 thorough reviews. 31, 32 Posterior minimal access approaches are perhaps easier to adopt due to familiarity of anatomy with traditional open approaches. Several minimal access retractor systems have been engineered to allow insertion of pedicle screws and vertebral body replacement cages with minimal disruption of normal anatomy by posterior transpedicular approaches. 
Thoracoscopic Procedures
Endoscopic procedures for minimal access to thoracic spine metastases allow surgery to be performed without the major morbidity of an open thoracotomy, and a lower risk of intercostal neuralgia, pleural effusions, and hematoma. 35, 36 However, the learning curve for these techniques is steeper than miniopen approaches, and may involve more blood loss and length of surgery than conventional techniques. 30 Thoracoscopic surgery necessitates additional investment in equipment, surgeon, and staff training, and requires an experienced assistant who is familiar with the technique. One study of thoracoscopic vertebral body resection found a mean operating time of 4.9 h, and patient stay of 8.2 days.
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ADVANCES IN PEDICLE SCREW TECHNOLOGY Percutaneous Pedicle Screws
Percutaneous pedicle screws, placed using a Jamshidi bone needle and Kirschner guide wires, have revolutionized the indications for posterior fixation (Figure 1) . Previously, surgery would be discouraged in patients with an anticipated life expectancy of less than 3 months. However, clinicians often do not correctly estimate a patient's life expectancy, 38 and patients with a poor life expectancy may nevertheless benefit from stabilization to help back pain. Percutaneous pedicle screws may be offered to patients with poor prognosis for palliative stabilization and pain relief, and have effectively moved the goal posts for offering fixation surgery. Percutaneous screws have been used often for the treatment of lumbar degenerative disk disease, and small series have demonstrated lower complication rates and less atrophy of the multifidus spinal muscles compared to open approaches.
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Carbon Fiber Screws
Carbon-fiber-reinforced PEEK (poly-ether-ether-ketone) pedicle screws are now available from several manufacturers, with a high (greater than 60%) carbon fiber proportion (Figure 2) . Strength is uniquely provided by unidirectional extruded carbon fibers, and is equivalent to standard titanium screws. Short nonmetal carbon fiber rods are also available, allowing a radiolucent fixation system to be employed for spinal metastases (Figure 3 ). These systems have 2 main advantages: by decreasing the artifact on MRI or CT imaging, screw placement and surveillance for tumor recurrence is easier to observe; and carbon fiber constructs are associated with less shielding and scattering of radiotherapy which is often used for patients with spinal metastases after surgery, allowing higher and more accurate dose delivery.
Over the past few decades, the proportion of elderly patients in society has increased. Combined with better medical treatment of primary tumors and improved survival, it is now more common for patients to present with metastatic disease and coexistent osteoporotic vertebrae. Pedicle screws have been developed with fenestrations that allow PMMA bone cement to be injected through the screw into the vertebral body to decrease the risk of screw pull-out and failure. 41, 42 An alternative strategy to minimize screw failure is to use expandable screws. After insertion of the pedicle screw, an internal mechanism shortens the screw and allows the slotted tip to expand, thereby increasing the purchase of the screw within osteoporotic bone. 43 In patients with spinal metastases, bone fusion is often limited by poor nutrition, healing, chemotherapy, and radiotherapy. Some surgeons do not use bone graft in cases of metastatic disease due to limited life expectancy and a theoretical increased risk of infection due to the presence of a foreign body. The use of artificial hydroxyapatite putty as a bone graft substitute is gaining popularity, and decreases the risks of infection, pain, and fracture associated with harvest of iliac crest graft, which may also be affected by metastatic disease.
INTERDISCIPLINARY TEAM WORKING
The majority of patients with metastatic spine disease should be discussed in a multidisciplinary forum including spine surgeons, oncologists, radiotherapists, radiologists, pathologists, nurse practitioners, and ultimately with the patient, to determine the best treatment modality. Often, surgery may not be the preferred treatment option, and in particular, elderly patients or patients with a poor prognosis require considerable thought prior to surgical management. 44 A major advance in the treatment of spinal metastases has been the widespread realization that collective decision-making is essential to determine the best management for this complex patient group, and the development of weekly spine tumor meetings to discuss patient options is now common. In addition, multidisciplinary discussion and consultation can be facilitated using a "virtual consult" system using electronic communications techniques. 45 The multidisciplinary team would usually meet once a week to discuss cases, and also a mechanism is required for urgent discussion of cases which cannot wait until the next meeting. The oncologist in the team will often triage cases, and discuss patients who may benefit from surgical management. Prognosis can be estimated by oncologists and surgeons, considering the nonsurgical treatment options and how these may affect overall quality of life and disease progression. Spine surgeons will determine which surgical treatment options might be indicated, and the relative risk-benefit balance of a procedure, the likelihood of success, and whether patients will tolerate a particular operation or intervention. Oncologists will determine the efficacy of radiation treatment options or alternative medical management. Pathologists and radiologists in the team will permit interpretation of the histological and radiological data which is necessary to make appropriate decisions, and physical therapists and nurse practitioners are invaluable for recovery and the physical and psychological well-being of the patient. All members of the multidisciplinary team will contribute to the ethical and moral aspects of patient management, documentation, and communication of the decision-making process.
The Spinal Instability Neoplastic Score (SINS) is a unique tool that was developed by an interdisciplinary team, to allow specialists and nonspecialists alike to quantify the degree of instability associated with spinal metastases. 46 It is a reliable and valid tool which aids communication between oncologists, radiologists, and surgeons, and allows uniform reporting in the spine tumor literature, 47 although the prognostic value of SINS remains to be determined. 48 
ADVANCES IN MATERIALS AND ENGINEERING
PEEK and carbon-fiber-reinforced PEEK are now widely available materials used for vertebral body replacement cages, and pedicle screw-rod systems. They have excellent resilience and similar strength to titanium constructs, but with the advantage of radiolucency for subsequent imaging, and improved radiation treatment delivery. 49 Modern engineering of expandable cages allows easier insertion of a smaller cage which is then expanded in Situ and can be filled with bone graft or artificial bone substitutes. Titanium products continue to be used widely, with excellent handling characteristics, and visibility on X-ray which allows easy insertion and surveillance.
In many units, the use of PMMA bone cement is re-emerging, allowing custom shaping of supports and constructs at the time of surgery, secured in Situ by press fit or the use of Kirschner wires to stabilize the cement block, or containing the cement within mesh or block cage. 50 Three-dimensional printing of plastic polymer or titanium constructs is a new development which allows custom shapes and supports to be created for individual patients, after CTscan planning. This technique is of particular value for regions with complex anatomy including the upper cervical spine and craniovertebral junction. 51 Polymer or titanium powder is built up in successive 2-dimensional layers to create a computer-generated 3-dimensional structure which can be used as a custom implant.
Frameless spine navigation and robot-assisted guidance allow accurate tumor resection and placement of pedicle screws, with potentially better accuracy and less radiation exposure than conventional pedicle screw techniques.
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CONCLUSION
Surgery plays a pivotal role in the management of patients with symptomatic spinal metastases. Good technical surgery performed in appropriate situations can dramatically improve quality of life and survival. However, occasional complications of surgery can have a negative impact on the patient, particularly in those patients with a poor prognosis and limited life expectancy. Although improvements in the medical management of cancer potentially may decrease the need for surgery in the future, it may also have the opposite effect: to increase the number of patients presenting to surgeons in advanced age and with more extensive spinal metastases. Navigated minimal access surgery, with fewer complications and less postoperative pain, is likely to have an important role in the future, hand-in-hand with advances in immunotherapy and radiation techniques. The multimodality treatment of spinal metastases requires close communication across several medical and surgical specialties, and open discussion with the patient to decide the most appropriate treatment plan in each case.
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